Inflammatory Bowel Diseases
"Inflammatory Bowel Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
| Descriptor ID |
D015212
|
| MeSH Number(s) |
C06.405.205.731 C06.405.469.432
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Inflammatory Bowel Diseases".
Below are MeSH descriptors whose meaning is more specific than "Inflammatory Bowel Diseases".
This graph shows the total number of publications written about "Inflammatory Bowel Diseases" by people in this website by year, and whether "Inflammatory Bowel Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 3 | 0 | 3 |
| 2010 | 0 | 1 | 1 |
| 2011 | 4 | 1 | 5 |
| 2012 | 2 | 1 | 3 |
| 2013 | 4 | 1 | 5 |
| 2014 | 2 | 0 | 2 |
| 2015 | 3 | 0 | 3 |
| 2016 | 8 | 0 | 8 |
| 2017 | 119 | 22 | 141 |
| 2018 | 133 | 20 | 153 |
| 2019 | 67 | 7 | 74 |
| 2020 | 98 | 9 | 107 |
| 2021 | 53 | 4 | 57 |
| 2022 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Inflammatory Bowel Diseases" by people in Profiles.
-
Effect of inflammatory bowel disease and related medications on COVID-19 incidence, disease severity, and outcome: the Israeli experience. Eur J Gastroenterol Hepatol. 2022 03 01; 34(3):267-273.
-
T Cell Response After SARS-CoV-2 Vaccination in Immunocompromised Patients with Inflammatory Bowel Disease. J Crohns Colitis. 2022 Feb 23; 16(2):251-258.
-
Patient-led Remote IntraCapillary pharmacoKinetic Sampling (fingerPRICKS) for Therapeutic Drug Monitoring in patients with Inflammatory Bowel Disease. J Crohns Colitis. 2022 Feb 23; 16(2):190-198.
-
New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International Registry. Inflamm Bowel Dis. 2022 02 01; 28(2):314-317.
-
Perceptions and Behaviors of Patients with Inflammatory Bowel Disease during the COVID-19 Crisis. Gut Liver. 2022 01 15; 16(1):81-91.
-
Elevated Adherence to Vaccination Against SARS-CoV-2 Among Patients with Inflammatory Bowel Disease. J Crohns Colitis. 2021 Dec 18; 15(12):2142-2143.
-
The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBD. Eur J Gastroenterol Hepatol. 2021 12 01; 33(1S Suppl 1):e810-e817.
-
SARS-CoV-2 Immunization in Patients With Inflammatory Bowel Disease May Result in Disease Flares. Am J Gastroenterol. 2021 12 01; 116(12):2480-2481.
-
Gastric cancer, inflammatory bowel disease and polyautoimmunity in a 17-year-old boy: CTLA-4 deficiency successfully treated with Abatacept. Eur J Gastroenterol Hepatol. 2021 12 01; 33(1S Suppl 1):e1051-e1056.
-
The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry. J Crohns Colitis. 2021 Nov 08; 15(11):1877-1884.